Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China flag China · Delayed Price · Currency is CNY
16.21
+0.69 (4.45%)
Sep 16, 2026, 3:00 PM CST

SHA:600521 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
627.82266.41,119830.471,168487.54
Depreciation & Amortization
1,048998.02916.77780.37672.01563.07
Other Amortization
32.2526.6915.89.257.082.45
Loss (Gain) From Sale of Assets
-23.35-0-2.330.29-3.59-0.6
Asset Writedown & Restructuring Costs
54.1653.630.1339.4121.6910.35
Loss (Gain) From Sale of Investments
-269.57-69.4597.72161.9766.48-442.95
Provision & Write-off of Bad Debts
-14.77-9.0336.58-7.9345.3714.73
Other Operating Activities
463.59393.59229.27241.6986.91220.3
Change in Accounts Receivable
46.49-126.34-786.09269.5-818.89-388.87
Change in Inventory
-471.61-471.61-78.33-140.05-679.92-386.81
Change in Accounts Payable
122.08165.02597.6819.99669.89679.92
Change in Other Net Operating Assets
341.648.3114.14-0.4981.61113.74
Operating Cash Flow
1,9591,2302,1732,2171,243938.43
Operating Cash Flow Growth
57.38%-43.38%-2.00%78.41%32.42%-39.67%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,918-1,966-1,853-1,592-2,316-2,434
Sale of Property, Plant & Equipment
34.589.955.24.8410.729.94
Cash Acquisitions
-6.53-----
Investment in Securities
118.2586.27-72.57-18.7-106.6658.19
Other Investing Activities
2.282.280.43-16.53-20.359.48
Investing Cash Flow
-1,617-1,868-1,920-1,623-2,433-2,357

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-4,7266,2023,3213,8733,238
Long-Term Debt Repaid
--4,337-5,637-3,321-2,732-1,931
Lease Payments
-34.45-33.41-21.53-22.17-21.78-16.16
Net Debt Issued (Repaid)
760.41388.58564.79-0.61,1401,307
Issuance of Common Stock
-591.52--37.68371.82
Repurchase of Common Stock
---189.92-71-172.43-150.01
Common Dividends Paid
-697.07-546.18-475.36-556.01-318.32-387.21
Other Financing Activities
-26.89183.16-32.42-16.63-78.36-23.31
Financing Cash Flow
36.44617.07-132.91-644.23609.041,118

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-125.28-10.6551.162954.65-43.49
Net Cash Flow
252.24-31.05170.63-20.98-526.18-343.57

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
40.26-735.96319.33624.63-1,074-1,496
Free Cash Flow Growth
---48.88%---
Free Cash Flow Margin
0.45%-8.57%3.35%7.52%-12.99%-22.52%
Free Cash Flow Per Share
0.03-0.500.220.43-0.73-1.04
Levered Free Cash Flow
-363.59-887.07-478.3615.26-1,715-1,721
Unlevered Free Cash Flow
-214.3-741.07-340.99160.07-1,578-1,617
Free Cash Flow After Leases
5.81-769.37297.8602.47-1,095-1,512

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.060.060.060.060.060.06
Cash Income Tax Paid
233.92391.44568.31614.3206.43227.84
Change in Working Capital
40.27-429.72-270.27161.5-821.0283.55